Rex L. Mahnensmith

1.8k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Rex L. Mahnensmith is a scholar working on Nephrology, Surgery and Molecular Biology. According to data from OpenAlex, Rex L. Mahnensmith has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Rex L. Mahnensmith's work include Dialysis and Renal Disease Management (6 papers), Cardiovascular Syncope and Autonomic Disorders (4 papers) and Hemodynamic Monitoring and Therapy (4 papers). Rex L. Mahnensmith is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Cardiovascular Syncope and Autonomic Disorders (4 papers) and Hemodynamic Monitoring and Therapy (4 papers). Rex L. Mahnensmith collaborates with scholars based in United States, Austria and Taiwan. Rex L. Mahnensmith's co-authors include Peter S. Aronson, Mark A. Perazella, John Concato, Paul D. Kirwin, Suzanne Watnick, Dinna N. Cruz, Ali K. Abu‐Alfa, Marcelo Orías, D. N. Cruz and Jeffrey Topal and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation Research.

In The Last Decade

Rex L. Mahnensmith

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes.

1985 434 citations Rex L. Mahnensmith, Peter S. Aronson profile →

Peers

Countries citing papers authored by Rex L. Mahnensmith

Since Specialization

Citations

This map shows the geographic impact of Rex L. Mahnensmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rex L. Mahnensmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rex L. Mahnensmith more than expected).

Fields of papers citing papers by Rex L. Mahnensmith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rex L. Mahnensmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rex L. Mahnensmith. The network helps show where Rex L. Mahnensmith may publish in the future.

Co-authorship network of co-authors of Rex L. Mahnensmith

This figure shows the co-authorship network connecting the top 25 collaborators of Rex L. Mahnensmith. A scholar is included among the top collaborators of Rex L. Mahnensmith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rex L. Mahnensmith. Rex L. Mahnensmith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Experience with outpatient computed tomographic-guided renal biopsy 2010 ·Clinical Nephrology ·(unknown), Mark A. Perazella, Rex L. Mahnensmith, Ali K. Abu‐Alfa	10
2	A Quality Improvement Model for Optimizing Care of the Diabetic End‐Stage Renal Disease Patient 2010 ·Seminars in Dialysis ·Rex L. Mahnensmith, (unknown), Yueh‐Han Hsu, Mark E. Williams	8
3	Successful Use of Intraperitoneal Daptomycin in the Treatment of Vancomycin-Resistant Enterococcus Peritonitis 2009 ·American Journal of Kidney Diseases ·Sarah C. Huen, Isaac E. Hall, Jeffrey Topal, Rex L. Mahnensmith, Ursula C. Brewster, Ali K. Abu‐Alfa	31
4	Prostatic Abscess With Candida glabrata Treated With Micafungin 2008 ·Infectious Diseases in Clinical Practice ·Shaili Gupta, (unknown), Rex L. Mahnensmith, Jeffrey Topal	3
5	Intradialytic Administration of Amphotericin B: Clinical Observations on Efficacy and Safety 2004 ·The American Journal of the Medical Sciences ·(unknown), (unknown), Rex L. Mahnensmith, Mark A. Perazella	2
6	Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine 2002 ·American Journal of Kidney Diseases ·(unknown), Ali K. Abu‐Alfa, Rex L. Mahnensmith, Mark A. Perazella	40
7	The prevalence and treatment of depression among patients starting dialysis 2002 ·American Journal of Kidney Diseases ·Suzanne Watnick, Paul D. Kirwin, Rex L. Mahnensmith, John Concato	271
8	Pericarditis Associated with Renal Failure: Evolution and Management 2001 ·Seminars in Dialysis ·(unknown), Rex L. Mahnensmith	23
9	Treatment of Severe Intradialytic Hypotension With the Addition of High Dialysate Calcium Concentration to Midodrine and/or Cool Dialysate 2001 ·American Journal of Kidney Diseases ·(unknown), Dinna N. Cruz, Ali K. Abu‐Alfa, Rex L. Mahnensmith, Mark A. Perazella	27
10	Ace inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients 2000 ·American Journal of Kidney Diseases ·Ali K. Abu‐Alfa, Dinna N. Cruz, Mark A. Perazella, Rex L. Mahnensmith, David B. Simon, Margaret J. Bia	32
11	Extreme Hyperphosphatemia and Acute Renal Failure after a Phosphorus-Containing Bowel Regimen 1999 ·American Journal of Nephrology ·Marcelo Orías, Rex L. Mahnensmith, Mark A. Perazella	57
12	Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension 1999 ·American Journal of Kidney Diseases ·Dinna N. Cruz, Rex L. Mahnensmith, (unknown), (unknown)	62
13	Malignant Hypertension 1998 ·New England Journal of Medicine ·Mark A. Perazella, Rex L. Mahnensmith	0
14	Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up. 1998 ·PubMed ·D. N. Cruz, Rex L. Mahnensmith, (unknown), Mark A. Perazella	32
15	Intradialytic hypotension: Is midodrine beneficial in symptomatic hemodialysis patients? 1997 ·American Journal of Kidney Diseases ·Dinna N. Cruz, Rex L. Mahnensmith, Mark A. Perazella	32
16	Hyperkalemia in the elderly 1997 ·Journal of General Internal Medicine ·(unknown), Rex L. Mahnensmith	87
17	Bone marrow transplant nephropathy 1997 ·Journal of the American Society of Nephrology ·D. N. Cruz, (unknown), Rex L. Mahnensmith	24
18	Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance? 1996 ·American Journal of Kidney Diseases ·Dinna N. Cruz, Mark A. Perazella, Ali K. Abu‐Alfa, Rex L. Mahnensmith	40
19	Advances in nephrology: a selected review of progress in care of the patient with renal failure. 1990 ·PubMed ·Rex L. Mahnensmith	0
20	Interrelationships among quinidine, amiloride, and lithium as inhibitors of the renal Na+-H+ exchanger. 1985 ·Journal of Biological Chemistry ·Rex L. Mahnensmith, Peter S. Aronson	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact